Clinical Trial Update: Safety and Efficacy of NPI-001 Tablets for RP Associated With Usher Syndrome [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on a Phase 1/2 clinical trial of NPI-001 tablets for retinitis pigmentosa associated with Usher syndrome, currently active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa
• Usher Syndrome

Drugs mentioned

• NPI-001

Snippet

Sponsor: Nacuity Pharmaceuticals, Inc. | Conditions: Usher Syndromes | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING